Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 118 entries
Sorted by: Best Match Show Resources per page
Uptake of best practice recommendations in the management of patients with diabetes and periodontitis: a cross-sectional survey of dental clinicians.

British dental journal

Bissett SM, Presseau J, Rapley T, Preshaw PM.
PMID: 30655620
Br Dent J. 2019 Jan 18; doi: 10.1038/sj.bdj.2019.48. Epub 2019 Jan 18.

No abstract available.

Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents.

Pediatric blood & cancer

Schneider DT, Orbach D, Ben-Ami T, Bien E, Bisogno G, Brecht IB, Cecchetto G, Ferrari A, Godzinski J, Janic D, Lopez Almaraz R, Pourtsidis A, Roganovic J, Schultz KAP, Stachowicz-Stencel T, Fresneau B.
PMID: 33760357
Pediatr Blood Cancer. 2021 Jun;68:e29017. doi: 10.1002/pbc.29017. Epub 2021 Mar 24.

As part of the European Union-funded project designated Paediatric Rare Tumours Network - European Registry (PARTNER), the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) is continuously developing consensus recommendations in order to harmonize standard care for very...

Study conclude that TXA in severely injured was associated with lower mortality: beware of potential confounders.

Critical care (London, England)

Honore PM, Redant S, Preseau T, Moorthamers S, Kaefer K, Barreto Gutierrez L, Attou R, Gallerani A, Boer W, De Bels D.
PMID: 34724963
Crit Care. 2021 Nov 01;25(1):379. doi: 10.1186/s13054-021-03790-4.

No abstract available.

Adrenocortical tumours in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations.

Pediatric blood & cancer

Virgone C, Roganovic J, Vorwerk P, Redlich A, Schneider DT, Janic D, Bien E, López-Almaraz R, Godzinski J, Osterlundh G, Stachowicz-Stencel T, Brugières L, Brecht IB, Thomas-Teinturier C, Fresneau B, Surun A, Ferrari A, Bisogno G, Orbach D.
PMID: 34174161
Pediatr Blood Cancer. 2021 Jun;68:e29025. doi: 10.1002/pbc.29025.

Adrenocortical tumours (ACTs) are rare during childhood. A complete surgical resection provides the best chance of cure, but the role and efficacy of the adjuvant therapy are still controversial. Various histologic criteria of malignancy for ACTs adopted in children...

Patient engagement in preclinical laboratory research: A scoping review.

EBioMedicine

Fox G, Fergusson DA, Daham Z, Youssef M, Foster M, Poole E, Sharif A, Richards DP, Hendrick K, Mendelson AA, Macala KF, Monfaredi Z, Montroy J, Fiest KM, Presseau J, Lalu MM.
PMID: 34280783
EBioMedicine. 2021 Aug;70:103484. doi: 10.1016/j.ebiom.2021.103484. Epub 2021 Jul 17.

BACKGROUND: 'Patient engagement' involves meaningful collaboration between researchers and 'patient partners' to co-create research. It helps ensure that research being conducted is relevant to its ultimate end-users. Although patient engagement within clinical research has been well documented, the prevalence...

Barriers and enablers to diabetic eye screening attendance: an interview study with young adults with type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association

Prothero L, Lawrenson JG, Cartwright M, Crosby-Nwaobi R, Burr JM, Gardner P, Anderson J, Presseau J, Ivers N, Grimshaw JM, Lorencatto F.
PMID: 34837256
Diabet Med. 2021 Nov 27;e14751. doi: 10.1111/dme.14751. Epub 2021 Nov 27.

AIM: To identify barriers and enablers of diabetic eye screening (DES) attendance amongst young adults with diabetes living in the UK.METHODS: Semi-structured qualitative interviews with adults aged 18-34 years with diabetes. Participants were purposively sampled to aim for representation...

How can behavioural science help us design better trials?.

Trials

Gillies K, Brehaut J, Coffey T, Duncan EM, Francis JJ, Hey SP, Presseau J, Weijer C, Campbell MK.
PMID: 34863274
Trials. 2021 Dec 04;22(1):882. doi: 10.1186/s13063-021-05853-x.

No abstract available.

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

Nature communications

Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, Arnold N, Aronson KJ, Arun BK, Augustinsson A, Azzollini J, Barrowdale D, Baynes C, Becher H, Bermisheva M, Bernstein L, Białkowska K, Blomqvist C, Bojesen SE, Bonanni B, Borg A, Brauch H, Brenner H, Burwinkel B, Buys SS, Caldés T, Caligo MA, Campa D, Carter BD, Castelao JE, Chang-Claude J, Chanock SJ, Chung WK, Claes KBM, Clarke CL, Collée JM, Conroy DM, Czene K, Daly MB, Devilee P, Diez O, Ding YC, Domchek SM, Dörk T, Dos-Santos-Silva I, Dunning AM, Dwek M, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Flyger H, Fostira F, Friedman E, Fritschi L, Frost D, Gago-Dominguez M, Gapstur SM, Garber J, Garcia-Barberan V, García-Closas M, García-Sáenz JA, Gaudet MM, Gayther SA, Gehrig A, Georgoulias V, Giles GG, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Harrington PA, Hart SN, He W, Hogervorst FBL, Hollestelle A, Hopper JL, Horcasitas DJ, Hulick PJ, Hunter DJ, Imyanitov EN, Jager A, Jakubowska A, James PA, Jensen UB, John EM, Jones ME, Kaaks R, Kapoor PM, Karlan BY, Keeman R, Khusnutdinova E, Kiiski JI, Ko YD, Kosma VM, Kraft P, Kurian AW, Laitman Y, Lambrechts D, Le Marchand L, Lester J, Lesueur F, Lindstrom T, Lopez-Fernández A, Loud JT, Luccarini C, Mannermaa A, Manoukian S, Margolin S, Martens JWM, Mebirouk N, Meindl A, Miller A, Milne RL, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H, Nielsen FC, O'Brien KM, Olopade OI, Olson JE, Olsson H, Osorio A, Ottini L, Park-Simon TW, Parsons MT, Pedersen IS, Peshkin B, Peterlongo P, Peto J, Pharoah PDP, Phillips KA, Polley EC, Poppe B, Presneau N, Pujana MA, Punie K, Radice P, Rantala J, Rashid MU, Rennert G, Rennert HS, Robson M, Romero A, Rossing M, Saloustros E, Sandler DP, Santella R, Scheuner MT, Schmidt MK, Schmidt G, Scott C, Sharma P, Soucy P, Southey MC, Spinelli JJ, Steinsnyder Z, Stone J, Stoppa-Lyonnet D, Swerdlow A, Tamimi RM, Tapper WJ, Taylor JA, Terry MB, Teulé A, Thull DL, Tischkowitz M, Toland AE, Torres D, Trainer AH, Truong T, Tung N, Vachon CM, Vega A, Vijai J, Wang Q, Wappenschmidt B, Weinberg CR, Weitzel JN, Wendt C, Wolk A, Yadav S, Yang XR, Yannoukakos D, Zheng W, Ziogas A, Zorn KK, Park SK, Thomassen M, Offit K, Schmutzler RK, Couch FJ, Simard J, Chenevix-Trench G, Easton DF, Andrieu N, Antoniou AC.
PMID: 33990587
Nat Commun. 2021 May 14;12(1):2986. doi: 10.1038/s41467-021-23162-4.

A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23162-4.

Multivariable analysis suggest that mechanical ventilation >48 h, the detection of an aneurysm, a lower Hunt and Hess grade and a pretreated psychiatric disorder were associated with the development of delirium: Beware of numerous potential confounders!.

Journal of critical care

Honore PM, Redant S, Moorthamers S, Preseau T, Kaefer K, Barreto Gutierrez L, Attou R, Gallerani A, De Bels D.
PMID: 34740481
J Crit Care. 2021 Nov 02; doi: 10.1016/j.jcrc.2021.10.011. Epub 2021 Nov 02.

No abstract available.

Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategies.

Hepatology international

Illiano M, Colinard M, Taque S, Mallon B, Larue C, Laithier V, Vérité-Goulard C, Sudour-Bonnange H, Faure-Conter C, Coze C, Aerts I, De Maricourt CD, Paillard C, Branchereau S, Brugières L, Fresneau B.
PMID: 34506008
Hepatol Int. 2021 Sep 10; doi: 10.1007/s12072-021-10251-1. Epub 2021 Sep 10.

BACKGROUND AND AIMS: Prognosis of hepatoblastoma patients has increased with cisplatin-based chemotherapy and high-quality resection including liver transplant. Consequently current risk-adapted therapeutic strategy aims to reduce long-term side effects in patients with standard risk disease.METHODS: We report long-term mortality...

Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID.

Critical care (London, England)

Honore PM, Redant S, Preseau T, Cismas BV, Kaefer K, Barreto Gutierrez L, Anane S, Attou R, Gallerani A, De Bels D.
PMID: 34906200
Crit Care. 2021 Dec 14;25(1):425. doi: 10.1186/s13054-021-03850-9.

No abstract available.

Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects.

Critical care (London, England)

Honore PM, Redant S, Preseau T, Cismas BV, Kaefer K, Barreto Gutierrez L, Anane S, Attou R, Gallerani A, De Bels D.
PMID: 34915896
Crit Care. 2021 Dec 16;25(1):433. doi: 10.1186/s13054-021-03854-5.

No abstract available.

Showing 13 to 24 of 118 entries